Editorial: Advancement in malaria treatment.
作者信息
Gunjan Sarika, Goyal Manish
机构信息
Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, United States.
Department of Molecular and Cell Biology, Boston University Goldman School of Dental Medicine, Boston, MA, United States.
出版信息
Front Cell Infect Microbiol. 2025 May 28;15:1628923. doi: 10.3389/fcimb.2025.1628923. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Advancement in malaria treatment.社论：疟疾治疗的进展
Front Cell Infect Microbiol. 2025 May 28;15:1628923. doi: 10.3389/fcimb.2025.1628923. eCollection 2025.
2
Emergence of artemisinin-based combination treatment failure in patients returning from sub-Saharan Africa with P. falciparum malaria.从撒哈拉以南非洲返回的恶性疟原虫疟疾患者出现青蒿素为基础的联合治疗失败。
J Travel Med. 2023 Dec 28;30(8). doi: 10.1093/jtm/taad114.
3
[Combined antimalarial therapy using artemisinin].[使用青蒿素的联合抗疟疗法]
Parassitologia. 2004 Jun;46(1-2):85-7.
4
Detection of novel coronin gene mutations in a recrudescent ACT-treated patient in South-Western Nigeria.在尼日利亚西南部一位 ACT 治疗后复发的患者中检测到新型冠状基因突变。
Front Cell Infect Microbiol. 2024 Apr 23;14:1366563. doi: 10.3389/fcimb.2024.1366563. eCollection 2024.
5
Prevalence of potential mediators of artemisinin resistance in African isolates of Plasmodium falciparum.青蒿素耐药性在非洲疟原虫分离株中潜在中介的流行情况。
Malar J. 2021 Dec 2;20(1):451. doi: 10.1186/s12936-021-03987-6.
6
Risk of selection and timelines for the continued spread of artemisinin and partner drug resistance in Africa.非洲青蒿素及联合用药耐药性持续传播的选择风险和时间线。
medRxiv. 2024 Aug 28:2024.08.28.24312699. doi: 10.1101/2024.08.28.24312699.
7
Artemisinin resistance and malaria elimination: Where are we now?青蒿素耐药性与疟疾消除：我们目前处于什么状况？
Front Pharmacol. 2022 Sep 23;13:876282. doi: 10.3389/fphar.2022.876282. eCollection 2022.
8
Surveillance of genetic markers associated with Plasmodium falciparum resistance to artemisinin-based combination therapy in Pakistan, 2018-2019.2018-2019 年在巴基斯坦对与青蒿素类复方疗法耐药相关的疟原虫遗传标记进行监测。
Malar J. 2020 Jun 8;19(1):206. doi: 10.1186/s12936-020-03276-8.
9
Potential Emergence of Plasmodium Resistance to Artemisinin Induced by the Use of Artemisia annua for Malaria and COVID-19 Prevention in Sub-African Region.青蒿素在撒哈拉以南非洲地区用于疟疾和 COVID-19 预防可能导致疟原虫对其产生抗药性。
Acta Parasitol. 2022 Mar;67(1):55-60. doi: 10.1007/s11686-021-00489-y. Epub 2021 Nov 19.
10
Absence of association between polymorphisms in the pfcoronin and pfk13 genes and the presence of Plasmodium falciparum parasites after treatment with artemisinin derivatives in Senegal.在塞内加尔，用青蒿素衍生物治疗后，pfcoronin 和 pfk13 基因多态性与疟原虫寄生虫的存在之间没有关联。
Int J Antimicrob Agents. 2020 Dec;56(6):106190. doi: 10.1016/j.ijantimicag.2020.106190. Epub 2020 Oct 9.
本文引用的文献
1
Global impact of parasitic infections and the importance of parasite control.寄生虫感染的全球影响及寄生虫控制的重要性。
Front Parasitol. 2025 Mar 10;4:1546195. doi: 10.3389/fpara.2025.1546195. eCollection 2025.
2
WHO world malaria report 2024.《世界卫生组织2024年疟疾报告》
Lancet Microbe. 2025 Feb 6:101073. doi: 10.1016/j.lanmic.2025.101073.
3
Artemisinin-resistant malaria.抗青蒿素疟疾
Clin Microbiol Rev. 2024 Dec 10;37(4):e0010924. doi: 10.1128/cmr.00109-24. Epub 2024 Oct 15.
4
Safety, pharmacokinetics, and antimalarial activity of the novel plasmodium eukaryotic translation elongation factor 2 inhibitor M5717: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection study.新型疟原虫真核翻译延伸因子 2 抑制剂 M5717 的安全性、药代动力学和抗疟活性：一项首次人体、随机、安慰剂对照、双盲、单次递增剂量研究和志愿者感染研究。
Lancet Infect Dis. 2021 Dec;21(12):1713-1724. doi: 10.1016/S1473-3099(21)00252-8. Epub 2021 Oct 26.
5
Triple Artemisinin-Based Combination Therapies for Malaria - A New Paradigm?三药联合疗法治疗疟疾——一种新模式？
Trends Parasitol. 2021 Jan;37(1):15-24. doi: 10.1016/j.pt.2020.09.011. Epub 2020 Oct 12.
6
Plasmodium vivax in the Era of the Shrinking P. falciparum Map.《在恶性疟原虫地图不断缩小的时代中的间日疟原虫》
Trends Parasitol. 2020 Jun;36(6):560-570. doi: 10.1016/j.pt.2020.03.009. Epub 2020 Apr 22.
7
Drug resistance in Plasmodium.疟原虫的耐药性。
Nat Rev Microbiol. 2018 Mar;16(3):156-170. doi: 10.1038/nrmicro.2017.161. Epub 2018 Jan 22.
8
Malaria Pathogenesis.疟疾发病机制。
Cold Spring Harb Perspect Med. 2018 Jan 2;8(1):a025569. doi: 10.1101/cshperspect.a025569.
9
Adjunctive therapy for cerebral malaria and other severe forms of Plasmodium falciparum malaria.脑型疟疾和其他严重的恶性疟原虫疟疾的辅助治疗。
Expert Rev Anti Infect Ther. 2010 Sep;8(9):997-1008. doi: 10.1586/eri.10.90.
Zotero 插件